10077 Marcia Barinaga: How much pain for cardiac gain?
Science 30 May 1997, 1324-1327.

H. Berger/Barry Zaret: Nuclear cardiology. 
New England J. Med. 305 (1981), 799-807.

Eberhard Betz (ed.): Herz und Blutkreislauf. Spektrum 1991.

Sergio Dalla Volta: Manuale delle malattie del cuore e dell'aorta.
McGraw-Hill, 700p. Lire 120.000. Per gli studenti.

7946 Anja Geisterfer-Lowrance a.o.: A mouse model of familial hypertrophic
cardiomyopathy. Science 3 May 1996, 731-734.

7941 Mark Keating/Michael Sanguinetti: Molecular genetic insights into 
cardiovascular disease. Science 3 May 1996, 681-685.

6093 Larry Kedes: Regulation of myocardial adaptation.
Science & Medicine 1994/3, 34-43.

6666 Lawrence Klein/William Miles: Radiofrequency ablation of cardiac 
arrhythmias. Science & Medicine May/June 1994, 48-57.

18539 Manuel Mayr/Basetti Madhu/Qingbo Xu: Proteomics and metabolomics
combined in cardiovascular research.
Trends Cardiovasc. Med. 17/2 (2007), 43-48.

6299 Antonio Muscari: Cardiologia al computer. EtasLibri 1994.

7939 Eric Olson/Deepak Srivastava: Molecular pathways controlling heart
development. Science 3 May 1996, 671-676.

Noel Rose: Immune mediated heart disease.
Springer 1997. 3-540-55614-1.

7546 Levin Santos: Sante'. The Sciences January/February 1996, 11.
The good news about wine (or perhaps phenols) keeps on flowing.

Vittorio Sartorelli/Masahiko Kurabayashi/Larry Kedes: Muscle-specific gene 
expression. Circulation Research 72 (1993), 925-931.

H. Schultheis''/P. Schwimmbeck (ed.): The role of immune mechanisms in
cardiovascular disease. Springer 1997. 3-540-61358-7. $100.

L. Shapiro/K. Fox: A colour atlas of physical signs in cardiovascular disease.
Wolfe. 0-7234-1573-0. Pds. 21.

Eric Topol a.o. (ed.): Textbook of cardiovascular medicine.
Lippincott-Raven 1998, 2730p. 0-397-51592-8. $125.

5283 Barry Zaret/Frans Wackers: Nuclear cardiology I.
New England J. Med. 329 (1993), 775-783.

5391 Barry Zaret/Frans Wackers: Nuclear cardiology II. Evaluation of 
ventricular function. New England J. Med. 329 (1993), 855-863.
Cardiac performance, or ventricular function, can be assessed with 
radionuclide techniques by either of two methods. The first involves analyzing
the initial transit of an intravenously administered radionuclide bolus as it 
traverses the central circulation. The second, more widely applied, technique 
for the radionuclide evaluation of ventricular performance is equilibrium 
radionuclide angiocardiography. This method uses conventional scintillation 
cameras.